Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen New Industries Biomedical Engineering Co., Ltd.
  6. Summary
    300832   CNE100003T39

SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.

(300832)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2023-01-30
55.25 CNY   -2.02%
2022Shenzhen New Industries Receives Provincial Registration Certificate for Parathyroid Hormone Kit
MT
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
01/18/2023 01/19/2023 01/20/2023 01/30/2023 01/31/2023 Date
55.8 57 55.9 56.39 55.25 Last
3236288 3101034 5494405 5529150 3962143 Volume
-1.45% +2.15% -1.93% +0.88% -2.02% Change
Estimated financial data (e)
Sales 2022 3 114 M 461 M 461 M
Net income 2022 1 232 M 182 M 182 M
Net cash position 2022 1 793 M 265 M 265 M
P/E ratio 2022 35,3x
Yield 2022 -
Sales 2023 4 011 M 594 M 594 M
Net income 2023 1 589 M 235 M 235 M
Net cash position 2023 3 094 M 458 M 458 M
P/E ratio 2023 27,4x
Yield 2023 -
Capitalization 43 433 M 6 431 M 6 431 M
EV / Sales 2022 13,4x
EV / Sales 2023 10,1x
Nbr of Employees 2 298
Free-Float 30,0%
More Financials
Company
Shenzhen New Industries Biomedical Engineering Co Ltd is a company engaged in research and development, production and sales of in-vitro diagnostics instruments and supporting reagents. The Company operates three segments, including Instruments and Supporting Software, Reagents, Accessories and Others. Instruments and Supporting Software segment is involved in the production and sales of MAGLUMI automatic... 
Read more
More about the company
Ratings of Shenzhen New Industries Biomedical Engineering Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
2022Shenzhen New Industries Receives Provincial Registration Certificate for Parathyroid Ho..
MT
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. Implements Final Cash Dividend..
CI
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. Approves Cash Dividend for 202..
CI
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces Profit Distribution ..
CI
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2021Shenzhen New Industries Biomedical Engineering Co.,..
CI
2021Shenzhen New Industries Biomedical Engineering Co.,..
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces New Appointments
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Announces 2020 Final Profit Di..
CI
2021Certain A Shares of Shenzhen New Industries Biomedical Engineering Co., Ltd. are subjec..
CI
2021Shenzhen New Industries Biomedical Engineering Co., Ltd. Reports Earnings Results for t..
CI
More news
News in other languages on SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
01/18ANALYSEN DES TAGES von Dow Jones Newswires (18.01.2023)
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. annonce ses résultats pour les..
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. annonce ses résultats pour le ..
2022Shenzhen New Industries Biomedical Engineering Co., Ltd. met en place un dividende fina..
2022Shenzhen New Industries Biomedical Engineering Co, Ltd. approuve le dividende en espèce..
More news
ETFs positioned on SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
VanEck New China ESG - USD1.12%-0.78%-NC
KraneShares MSCI All China Health Care Inde...0.66%-2.87%China
VanEck ChiNext ETF - USD0.38%0.34%-China
Global X MSCI China Health Care ETF - USD0.22%-3.25%China
Xtrackers Harvest CSI 500 China-A Shares Sm...0.2%0.06%China
More ETFs positioned on SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Chart SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Duration : Period :
Shenzhen New Industries Biomedical Engineering Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 55,25 CNY
Average target price 68,77 CNY
Spread / Average Target 24,5%
EPS Revisions
Managers and Directors
Wei Rao Chairman & General Manager
Chen Liu Ding Chief Financial Officer & Deputy General Manager
Deng Ke Liu Chairman-Supervisory Board
Dai Na Wang Independent Director
Qing Wei Zhang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.10.19%6 569
BIOMÉRIEUX-3.47%12 160
DIASORIN S.P.A.-7.59%6 992
AUTOBIO DIAGNOSTICS CO., LTD.6.53%5 822
10X GENOMICS, INC.24.51%5 193
NATERA, INC.4.51%4 577